Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xos (XOS) Cash & Equivalents (2020 - 2025)

Xos (XOS) has disclosed Cash & Equivalents for 6 consecutive years, with $14.0 million as the latest value for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 27.32% year-over-year to $14.0 million; the TTM value through Dec 2025 reached $14.0 million, up 27.32%, while the annual FY2025 figure was $14.0 million, 27.32% up from the prior year.
  • Cash & Equivalents was $14.0 million for Q4 2025 at Xos, roughly flat from $14.1 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $207.4 million in Q3 2021, with the low at $4.3 million in Q2 2022.
  • Historically, Cash & Equivalents has averaged $30.3 million across 5 years, with a median of $17.9 million in 2021.
  • The largest annual shift saw Cash & Equivalents surged 134189.08% in 2021 before it plummeted 89.6% in 2025.
  • Over 5 years, Cash & Equivalents stood at $16.1 million in 2021, then surged by 120.73% to $35.6 million in 2022, then tumbled by 67.33% to $11.6 million in 2023, then decreased by 5.53% to $11.0 million in 2024, then rose by 27.32% to $14.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $14.0 million in Q4 2025, $14.1 million in Q3 2025, and $8.8 million in Q2 2025.